IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals and Pharmaceuticals has published its unaudited financial results for the third quarter and nine months ended 31 December 2025 in Business Standard, Financial Express, Economic Times, and Punjabi Jagran. Total income from operations for Q3 FY26 stood at Rs 585.68 crore, up about 11% from Rs 527.37 crore in Q3 FY25, while net profit after tax was nearly flat at Rs 20.58 crore versus Rs 20.55 crore a year ago. For the nine-month period, net profit after tax rose about 22% to Rs 84.54 crore (from Rs 69.38 crore), with EPS of Rs 2.88 versus Rs 2.36. The Board has declared an interim dividend of Rs 1 per share (50%) on a face value of Rs 2, with 17 February 2026 fixed as the record date. The statutory auditors have issued an unmodified limited review report on the results.
Steady revenue growth and a healthy ~22% jump in nine-month profit signal operational improvement, though Q3 profits were flat, which may temper near-term excitement. The Rs 1 interim dividend offers a small but tangible payout to shareholders, and the 17 February record date is the key date to be eligible for it.